Use of (+)-α- (2,3-dimethoxyphenyl) -1- 2- (4-fluorophenyl) ethyl -4-piperidinemethanol or a prodrug thereof in the treatment of dementia and symptoms of dopamine-induced psychiatric disorders

摘要

The present invention is directed to use of (+)-alpha-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl)ethyl]-4-piperidinemethanol or its prodrug (Formula II) in treating patients for symptoms of dementia and dopamine induced psychosis.